DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Olanzapine And Fluoxetine Hydrochloride is a drug marketed by Par Pharm, Sandoz, and Teva Pharms. and is included in four NDAs.
The generic ingredient in OLANZAPINE AND FLUOXETINE HYDROCHLORIDE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.
Recent Clinical Trials for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Massachusetts General Hospital||Early Phase 1|
|National Alliance on Mental Illness||N/A|
|University of New Mexico||N/A|